|
SNX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29949999649881E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05790000093364E-08 |
| Normal-vs-Stage2 |
4.342500E-03 |
| Normal-vs-Stage3 |
4.999100E-03 |
| Normal-vs-Stage4 |
1.152250E-02 |
| Stage1-vs-Stage2 |
7.808400E-01 |
| Stage1-vs-Stage3 |
1.584180E-01 |
| Stage1-vs-Stage4 |
1.628370E-01 |
| Stage2-vs-Stage3 |
4.878800E-01 |
| Stage2-vs-Stage4 |
4.283000E-01 |
| Stage3-vs-Stage4 |
9.134200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67329999856136E-08 |
| Normal-vs-AfricanAmerican |
1.882470E-02 |
| Normal-vs-Asian |
6.143800E-01 |
| Caucasian-vs-AfricanAmerican |
6.501000E-01 |
| Caucasian-vs-Asian |
5.108000E-01 |
| AfricanAmerican-vs-Asian |
6.392600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.19139999999762E-05 |
| Normal-vs-Female |
6.34719998782174E-09 |
| Male-vs-Female |
5.821500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.351200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.58409999998044E-06 |
| Normal-vs-Age(61-80Yrs) |
3.44809999996976E-07 |
| Normal-vs-Age(81-100Yrs) |
6.039900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.199000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.553200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.357400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.749000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.801800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.242800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.236200E-03 |
| Normal-vs-Grade 2 |
2.71190003786614E-09 |
| Normal-vs-Grade 3 |
1.553390E-04 |
| Normal-vs-Grade 4 |
3.937400E-01 |
| Grade 1-vs-Grade 2 |
1.627590E-01 |
| Grade 1-vs-Grade 3 |
1.861590E-02 |
| Grade 1-vs-Grade 4 |
4.022600E-03 |
| Grade 2-vs-Grade 3 |
3.292400E-02 |
| Grade 2-vs-Grade 4 |
2.259700E-03 |
| Grade 3-vs-Grade 4 |
8.714300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63213886850144E-12 |
| Normal-vs-ccB subtype |
2.502800E-01 |
| ccA subtype-vs-ccB subtype |
1.37269995370559E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06790000176105E-08 |
| Normal-vs-N1 |
8.549800E-01 |
| N0-vs-N1 |
4.418000E-02 |
|
|
